SOL-116
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SOL-116, covering 2026-01-08 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts [Phase 1]